"cell survival" trang 8 - tải miễn phí từ tailieunhanh
Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
8    69    1
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy
8    32    1
A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer
8    39    1
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients

The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients
8    41    1
Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study
9    47    1
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma
7    43    1
Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer
9    64    1
Randomized phase III trial of amrubicin/ cisplatin versus etoposide/cisplatin as firstline treatment for extensive small-cell lung cancer

Randomized phase III trial of amrubicin/ cisplatin versus etoposide/cisplatin as firstline treatment for extensive small-cell lung cancer
8    60    1
Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival

Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival
16    73    1
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous nonsmall cell lung cancer in elderly patients: TORG1015

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous nonsmall cell lung cancer in elderly patients: TORG1015
7    51    1
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer

The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
9    30    1
MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes

MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
14    40    1
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
11    45    1
MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
11    93    1
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
8    29    1
Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer

Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer
9    58    1
Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases

Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
9    43    2
Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy

Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy
6    30    1
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
10    36    1
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
7    26    1